A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia

by Henk, Henry J., Paoli, Carly J., Gandra, Shravanthi R.
Published 2015

Erratum to: ‘Costs of treating cardiovascular events in Germany: a systematic literature review’

by Schmid, Tamara, Xu, Weiwei, Gandra, Shravanthi R., Michailov, Galin V.
Published 2016

Tumor Necrosis Factor-Blocker Dose Escalation in Rheumatoid Arthritis Patients in a Pharmacy Benefit Management Setting

by Blume, Steven W., Fox, Kathleen M., Joseph, George, Chuang, Chien-Chia, Thomas, Jessy, Gandra, Shravanthi R.
Published 2013

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting

by Bonafede, Machaon, Johnson, Barbara H., Fox, Kathleen M., Watson, Crystal, Gandra, Shravanthi R.
Published 2013

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia

by Bonafede, Machaon M, Johnson, Barbara H, Richhariya, Akshara, Gandra, Shravanthi R
Published 2015

Patient-level costs of major cardiovascular conditions: a review of the international literature

by Nicholson, Gina, Gandra, Shravanthi R, Halbert, Ronald J, Richhariya, Akshara, Nordyke, Robert J
Published 2016

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study

by Fox, Kathleen M., Wang, Li, Gandra, Shravanthi R., Quek, Ruben G. W., Li, Lu, Baser, Onur
Published 2016

Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures

by Song, Xue, Quek, Ruben G.W., Gandra, Shravanthi R., Cappell, Katherine A., Fowler, Robert, Cong, Ze
Published 2015

Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study

by Fox, Kathleen M, Yee, Jerry, Cong, Ze, Brooks, John M, Petersen, Jeffrey, Lamerato, Lois, Gandra, Shravanthi R
Published 2012

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

by Gandra, Shravanthi R., Villa, Guillermo, Fonarow, Gregg C., Lothgren, Mickael, Lindgren, Peter, Somaratne, Ransi, van Hout, Ben
Published 2016

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk

by Quek, Ruben G W, Fox, Kathleen M, Wang, Li, Li, Lu, Gandra, Shravanthi R, Wong, Nathan D
Published 2015

Acute and chronic impact of cardiovascular events on health state utilities

by Matza, Louis S, Stewart, Katie D, Gandra, Shravanthi R, Delio, Philip R, Fenster, Brett E, Davies, Evan W, Jordan, Jessica B, Lothgren, Mickael, Feeny, David H
Published 2015

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia

by Wang, Anthony, Richhariya, Akshara, Gandra, Shravanthi R., Calimlim, Brian, Kim, Lisa, Quek, Ruben G. W., Nordyke, Robert J., Toth, Peter P.
Published 2016

The relationship between Lp(a) and CVD outcomes: a systematic review

by Forbes, Carol A., Quek, Ruben G. W., Deshpande, Sohan, Worthy, Gill, Wolff, Robert, Stirk, Lisa, Kleijnen, Jos, Gandra, Shravanthi R., Djedjos, Stephen, Wong, Nathan D.
Published 2016